Cargando…
Current status and prospects of plant genome editing in Australia
Plant genome editing, particularly CRISPR-Cas biotechnologies, has rapidly evolved and drawn enormous attention all around the world in the last decade. The cutting-edge technologies have had substantial impact on precise genome editing for manipulating gene expression, stacking gene mutations, and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143062/ https://www.ncbi.nlm.nih.gov/pubmed/34054265 http://dx.doi.org/10.1007/s11627-021-10188-y |
_version_ | 1783696677376360448 |
---|---|
author | Zhang, Yan Restall, Jemma Crisp, Peter Godwin, Ian Liu, Guoquan |
author_facet | Zhang, Yan Restall, Jemma Crisp, Peter Godwin, Ian Liu, Guoquan |
author_sort | Zhang, Yan |
collection | PubMed |
description | Plant genome editing, particularly CRISPR-Cas biotechnologies, has rapidly evolved and drawn enormous attention all around the world in the last decade. The cutting-edge technologies have had substantial impact on precise genome editing for manipulating gene expression, stacking gene mutations, and improving crop agronomic traits. Following the global trends, investigations on CRISPR-Cas have been thriving in Australia, especially in agriculture sciences. Importantly, CRISPR-edited plants, classified as SDN-1 organisms (SDN: site-directed nuclease), have been given a green light in Australia, with regulatory bodies indicating they will not be classified as a genetically modified organism (GMO) if no foreign DNA is present in an edited plant. As a result, genome-edited products would not attract the onerous regulation required for the introduction of a GMO, which could mean more rapid deployment of new varieties and products that could be traded freely in Australia, and potentially to export markets. In the present review, we discuss the current status and prospects of plant genome editing in Australia by highlighting several species of interest. Using these species as case studies, we discuss the priorities and potential of plant genome editing, as well as the remaining challenges. |
format | Online Article Text |
id | pubmed-8143062 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-81430622021-05-25 Current status and prospects of plant genome editing in Australia Zhang, Yan Restall, Jemma Crisp, Peter Godwin, Ian Liu, Guoquan In Vitro Cell Dev Biol Plant Special Issue on Genome Editing Plant genome editing, particularly CRISPR-Cas biotechnologies, has rapidly evolved and drawn enormous attention all around the world in the last decade. The cutting-edge technologies have had substantial impact on precise genome editing for manipulating gene expression, stacking gene mutations, and improving crop agronomic traits. Following the global trends, investigations on CRISPR-Cas have been thriving in Australia, especially in agriculture sciences. Importantly, CRISPR-edited plants, classified as SDN-1 organisms (SDN: site-directed nuclease), have been given a green light in Australia, with regulatory bodies indicating they will not be classified as a genetically modified organism (GMO) if no foreign DNA is present in an edited plant. As a result, genome-edited products would not attract the onerous regulation required for the introduction of a GMO, which could mean more rapid deployment of new varieties and products that could be traded freely in Australia, and potentially to export markets. In the present review, we discuss the current status and prospects of plant genome editing in Australia by highlighting several species of interest. Using these species as case studies, we discuss the priorities and potential of plant genome editing, as well as the remaining challenges. Springer US 2021-05-24 2021 /pmc/articles/PMC8143062/ /pubmed/34054265 http://dx.doi.org/10.1007/s11627-021-10188-y Text en © The Society for In Vitro Biology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Special Issue on Genome Editing Zhang, Yan Restall, Jemma Crisp, Peter Godwin, Ian Liu, Guoquan Current status and prospects of plant genome editing in Australia |
title | Current status and prospects of plant genome editing in Australia |
title_full | Current status and prospects of plant genome editing in Australia |
title_fullStr | Current status and prospects of plant genome editing in Australia |
title_full_unstemmed | Current status and prospects of plant genome editing in Australia |
title_short | Current status and prospects of plant genome editing in Australia |
title_sort | current status and prospects of plant genome editing in australia |
topic | Special Issue on Genome Editing |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143062/ https://www.ncbi.nlm.nih.gov/pubmed/34054265 http://dx.doi.org/10.1007/s11627-021-10188-y |
work_keys_str_mv | AT zhangyan currentstatusandprospectsofplantgenomeeditinginaustralia AT restalljemma currentstatusandprospectsofplantgenomeeditinginaustralia AT crisppeter currentstatusandprospectsofplantgenomeeditinginaustralia AT godwinian currentstatusandprospectsofplantgenomeeditinginaustralia AT liuguoquan currentstatusandprospectsofplantgenomeeditinginaustralia |